logo

For the Inventor, By the Inventor

Harvard, MA, United States of America

Simon Stewart Jones

This inventor holds 10 USPTO granted patents and 17 published patent applications and 8 EPO patents. Top assignees: Acetylon Pharmaceuticals, Inc., H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Stewart Jones. Retrieved from https://idiyas.com/inventor/simon-stewart-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 90.0

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Boston, MA (US) (2016 - 2020)
  • Harvard, MA (US) (2016 - 2024)

Company Filing History:

goldMedal10 out of 35 
 
Acetylon Pharmaceuticals, Inc.
 patents
silverMedal1 out of 313 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12053468 - Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof (2024-08-06),
2. 11813261 - HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemia (2023-11-14),
3. 11497746 - Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof (2022-11-15),
4. 11337975 - Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof (2022-05-24),
5. 10722512 - Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitors (2020-07-28),
6. 9949972 - Combinations of histone deacetylase inhibitors and immunomodulatory drugs (2018-04-24),
7. 9833466 - Treatment of leukemia with histone deacetylase inhibitors (2017-12-05),
8. 9663825 - Biomarkers to identify patients that will respond to treatment and treating such patients (2017-05-30),
9. 9403779 - Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors (2016-08-02),
10. 9278963 - Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors (2016-03-08),

Title: The Innovative Mind of Simon Stewart Jones

Introduction: Simon Stewart Jones is a renowned inventor based in Harvard, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Simon Stewart Jones holds several patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems.

Career Highlights: With a background in engineering and a passion for problem-solving, Simon Stewart Jones has led numerous successful projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout his career, Simon Stewart Jones has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life. His ability to work in multidisciplinary teams has been key to his success.

Conclusion: Simon Stewart Jones continues to push the boundaries of innovation, inspiring the next generation of inventors to think outside the box and create solutions that make a difference in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…